Medically Assisted Treatment (MAT) for Substance Use: Benefits, Risks, and Long-Term Considerations

TL;DR

  • This article explains Medication-Assisted Treatment (MAT) for substance use disorders, covering FDA-approved medications (buprenorphine, methadone, and naltrexone), how they work, benefits and risks, and what to expect during treatment.
  • If you or a loved one in the Houston or Sugar Land area is considering MAT, this guide will help you make an informed decision about starting recovery.

Medication-Assisted Treatment, commonly called MAT, has become one of the most effective approaches for treating opioid and alcohol use disorders. By combining FDA-approved medications with counseling and behavioral therapies, MAT addresses both the physical dependence and psychological patterns that keep people trapped in the cycle of addiction.

If you or someone you love is struggling with substance use in the Houston or Sugar Land area, understanding your treatment options is a critical first step. This article is written for individuals and families who want clear, evidence-based information about MAT, including what it is, how it works, the benefits and risks, and what you should know before starting treatment.

By the end of this guide, you will understand how MAT medications work, which options are available, what the research says about long-term outcomes, and how to decide if MAT is the right choice for your personal recovery journey.

What Is Medication-Assisted Treatment (MAT) for Substance Use?

Medication-Assisted Treatment is a comprehensive approach to treating substance use disorders that combines FDA-approved medications with counseling and behavioral therapies. The Substance Abuse and Mental Health Services Administration (SAMHSA) defines MAT as a “whole-patient” approach designed to address the full scope of addiction,  not just the physical symptoms.

MAT is primarily used to treat opioid use disorder and alcohol use disorder. Research from the National Institute on Drug Abuse (NIDA) shows that this combined approach significantly improves treatment outcomes compared to behavioral therapy alone. The medications help normalize brain chemistry, reduce cravings, and block the euphoric effects of substances, while counseling addresses the underlying behavioral and emotional factors driving addiction.

According to the CDC, MAT is the recommended standard of care for opioid use disorder and can reduce opioid-related mortality by approximately 50%.

Which FDA-Approved Medications Are Used in MAT?

The U.S. Food and Drug Administration (FDA) has approved three primary medications for treating opioid use disorder: buprenorphine, methadone, and naltrexone. Each works differently and offers distinct advantages depending on the patient’s needs.

Buprenorphine is a partial opioid agonist that reduces cravings and withdrawal symptoms without producing the full euphoric effects of other opioids. Common formulations include Suboxone (combined with naloxone to prevent misuse), Sublocade (monthly injection), and daily tablets or films. Buprenorphine can be prescribed by qualified clinicians in office-based settings, making it significantly more accessible than methadone for many patients.

Methadone is a full opioid agonist that has been used to treat opioid dependence since the 1960s. It effectively eliminates withdrawal symptoms and reduces cravings. Methadone is only available through federally certified Opioid Treatment Programs, requiring patients to visit clinics daily during initial treatment phases. A 1997 NIH Panel concluded that methadone maintenance treatment’s safety and efficacy have been “unequivocally established” by decades of research.

Naltrexone (Vivitrol) is an opioid antagonist that blocks the effects of opioids entirely. Unlike buprenorphine and methadone, naltrexone carries no risk of physical dependence. It is available as a daily oral tablet or a monthly extended-release injection administered by a clinician. Patients must be fully detoxed from opioids for 7–10 days before starting naltrexone.

How Does MAT Actually Work in the Brain and Body?

Understanding how MAT medications work helps explain why they are so effective. Opioid use disorder fundamentally changes how the brain processes reward, pain, and motivation. Over time, the brain becomes dependent on external opioids to maintain chemical balance.

Buprenorphine and methadone both act on the same brain receptors as heroin, fentanyl, and prescription opioids, but in controlled, safer ways. Methadone fully activates opioid receptors, providing enough stimulation to prevent withdrawal and cravings without causing euphoria when taken as prescribed. Buprenorphine only partially activates these receptors, creating a “ceiling effect” that dramatically reduces overdose risk.

Naltrexone works through a completely different mechanism. It binds to opioid receptors and blocks them, preventing any opioid from producing euphoric effects. This makes naltrexone ideal for patients who have already completed detoxification and want to prevent relapse.

All three medications allow the brain to gradually recover while giving patients stability to engage in counseling and rebuild their lives. As NIDA confirms, MAT works best when combined with counseling and recovery services.

What Are the Main Benefits of Choosing MAT for Recovery?

The benefits of MAT extend far beyond simply reducing drug use. Research consistently shows that patients in MAT programs experience dramatic improvements across multiple areas of life.

Benefit

Description

Reduced Overdose Risk 

Treatment with buprenorphine or methadone is associated with a 76% reduction in overdose risk during the first 3 months compared to no treatment. MAT provides life-saving protection, especially during the vulnerable early recovery period.

Improved Treatment Retention

Research shows that patients receiving MAT stay in treatment longer than those receiving behavioral therapy alone. Methadone has demonstrated the highest treatment retention rates among MAT options.

Better Quality of Life

MAT improves patients’ ability to gain and maintain employment, rebuild family relationships, and participate in their communities. MAT also reduces criminal activity and improves birth outcomes for pregnant women with substance use disorders.

Lower Risk of Infectious Disease

By reducing relapse and illicit drug use, MAT significantly lowers the risk of contracting HIV and hepatitis C through reduced needle sharing and risky behaviors.

What Risks and Side Effects Should Patients Know About?

While MAT is highly effective, patients should understand potential risks before starting. Common side effects include constipation, nausea, drowsiness, headache, and dry mouth. These typically improve within the first few weeks. More serious but rare risks include respiratory depression when combined with alcohol or benzodiazepines, liver problems, and allergic reactions.

Physical dependence is another important consideration. Both methadone and buprenorphine can produce physical dependence when used long-term, meaning stopping suddenly causes withdrawal symptoms. However, dependence under medical supervision is fundamentally different from addiction. Tapering gradually under a doctor’s guidance minimizes discomfort.

There is also a small risk of misuse. Buprenorphine has a ceiling effect that limits overdose potential, but diversion remains a concern. Suboxone contains naloxone to prevent injection misuse. Methadone’s daily clinic dispensing requirement also helps prevent misuse. At Skyward Treatment Center, we emphasize that medication supports recovery but does not replace counseling and personal growth.

How Long Should Patients Stay on MAT Medications?

According to SAMHSA, MAT medications are safe for long-term use, ranging from months to a lifetime. Research shows that individuals who remained in MAT programs for at least two years had a 70% chance of maintaining sobriety after completing treatment.

Some patients use MAT as a bridge through early recovery, tapering off after 6–12 months once they have built strong support systems. Others benefit from continuing MAT indefinitely, similar to managing diabetes or hypertension. The CDC emphasizes that stopping MAT should never be rushed, meaning that tapering should happen gradually with medical supervision, as abrupt discontinuation increases overdose risk.

What Should You Consider Before Starting MAT?

Deciding to begin MAT is a significant step. Here are the key factors patients in the Houston and Sugar Land area should consider when evaluating whether MAT is right for them.

  • Your Substance Use History: MAT is indicated for opioid and alcohol use disorders involving fentanyl, heroin, prescription painkillers, or alcohol dependence. A clinical assessment at a qualified treatment center determines your specific needs.
  • Commitment to Comprehensive Treatment: Medications alone are not enough. SAMHSA and the CDC both emphasize that MAT must include counseling for optimal outcomes. Ask yourself if you are ready to engage in therapy and support groups.
  • Medical History: Certain conditions affect which MAT medication is safest. Discuss your complete history, including mental health, with your provider. Co-occurring disorders are common and treatable through integrated care.
  • Support System: Recovery succeeds with supportive people around you. Skyward Treatment Center offers family programming to help rebuild these crucial relationships.

Frequently Asked Questions (FAQs) About MAT

No. MAT medications stabilize brain chemistry without producing the harmful highs of opioid misuse. The FDA emphasizes these are evidence-based treatments, not substitutions. Patients on MAT can work, drive, and live normal lives.

Physical dependence is possible with long-term use, but this is not the same as addiction. Dependence means your body has adapted to the medication and needs it to function normally. Addiction involves compulsive drug-seeking despite harm. Under medical supervision, MAT patients take medication as prescribed without addictive behaviors.

Most major insurance plans cover MAT. The Mental Health Parity Act requires insurers to cover substance use treatment comparably to physical health conditions. Skyward Treatment Center works with most major providers and offers same-day verification.

Yes. When taken as prescribed, MAT medications do not cause impairment that prevents working or driving. Once your dose is stabilized, you can resume normal daily activities including employment, school, and caring for your family. Many patients find that MAT actually improves their ability to work consistently because they are no longer dealing with the chaos of active addiction.

Take the First Step Toward Recovery

Recovery is possible, and you do not have to do it alone. A healthier, more fulfilling life awaits. 

Call Skyward Treatment Center at (713) 835-4771 or visit our website to verify your insurance and begin your journey today.

Table of Contents
Scroll to Top